Clarus Lifesciences II, L.P. Insider Trading
Get free email notifications about insider trading for Clarus Lifesciences II, L.P..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clarus Lifesciences II, L.P.. Clarus Lifesciences II, L.P. is a 10% Owner in ACHILLION PHARMACEUTICALS INC ($ACHN) and a 10% Owner in AERIE PHARMACEUTICALS INC ($AERI) and a 10% Owner in TETRALOGIC PHARMACEUTICALS CORP ($TLOG) and a 10% Owner in Blackstone Group L.P. ($BX) and a 10% Owner in NanoString Technologies Inc ($NSTG) and a 10% Owner in Ophthotech Corp. ($OPHT) and a 10% Owner in Restoration Robotics Inc ($HAIR) and a 10% Owner in CATABASIS PHARMACEUTICALS INC ($CATB).
Address: C/O CLARUS VENTURES, LLC 101 MAIN STREET, SUITE 1210 CAMBRIDGE 02142 MA
Companies in which Clarus Lifesciences II, L.P. is an Insider
ACHILLION PHARMACEUTICALS INC
Trading Symbol: ACHNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 3 shares
Current Value: $13
Latest Transaction: Jun 06 2012
$ACHN Market Capitalization: $579.52M
$ACHN Previous Close: $4.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AERIE PHARMACEUTICALS INC
Trading Symbol: AERIIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 30 2015
$AERI Market Capitalization: $1.50B
$AERI Previous Close: $42.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Blackstone Group Inc
Trading Symbol: BXIndustry: INVESTMENT ADVICE [6282]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 2,036,025 shares
Current Value: $62,200,564
Latest Transaction: Mar 22 2019
$BX Market Capitalization: $19.27B
$BX Previous Close: $30.55
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
CATABASIS PHARMACEUTICALS INC
Trading Symbol: CATBIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 2,752,488 shares
Current Value: $3,385,560
Latest Transaction: Jun 30 2015
$CATB Market Capitalization: $22.76M
$CATB Previous Close: $1.23
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IVERIC bio, Inc.
Trading Symbol: OPHTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 28 2015
$OPHT Market Capitalization: $156.71M
$OPHT Previous Close: $4.43
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NanoString Technologies Inc
Trading Symbol: NSTGIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 2,036,025 shares
Current Value: $38,704,835
Latest Transaction: Mar 22 2019
$NSTG Market Capitalization: $400.76M
$NSTG Previous Close: $19.01
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TETRALOGIC PHARMACEUTICALS Corp
Trading Symbol: TLOGIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 2,214,523 shares
Current Value: $132,871
Latest Transaction: Feb 10 2016
$TLOG Market Capitalization: $1.49M
$TLOG Previous Close: $0.06
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Venus Concept Inc.
Trading Symbol: VEROIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of Clarus Lifesciences II, L.P.: 10% Owner
Holdings: 3,389,105 shares
Latest Transaction: Oct 17 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Clarus Lifesciences II, L.P.
Sentiment: All, ACHN, AERI, BX, CATB, OPHT, NSTG, TLOG, VERO
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 22 2019 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 21.62 | 2,000,000 | 43,240,000 | 2,036,025 | 4 M to 2 M (-49.55 %) |
Mar 22 2019 | BX | Blackstone Group L ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 21.62 | 2,000,000 | 43,240,000 | 2,036,025 | 4 M to 2 M (-49.55 %) |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | X | 8.45 | 162,408 | 1,372,023 | 0 | |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Option Exercise | X | 8.45 | 162,408 | 1,372,023 | 0 | |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 15.99 | 85,823 | 1,372,310 | 4,036,025 | 4.1 M to 4 M (-2.08 %) |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Sell | S | 15.99 | 85,823 | 1,372,310 | 4,036,025 | 4.1 M to 4 M (-2.08 %) |
Sep 19 2018 | NSTG | NanoString Technol ... | Clarus Lifesciences II, L.P. | 10% Owner | Buy | X | 8.45 | 162,408 | 1,372,023 | 4,121,848 | 4 M to 4.1 M (+4.10 %) |